2004
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Approaches to control rate in atrial fibrillation
Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O'Neill G, Sharma A, Platia E, Feld GK, Akiyama T, Brodsky MA, Greene HL, Investigators A. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Approaches to control rate in atrial fibrillation. Journal Of The American College Of Cardiology 2004, 43: 1201-1208. PMID: 15063430, DOI: 10.1016/j.jacc.2003.11.032.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic beta-AntagonistsAgedAnti-Arrhythmia AgentsAtrial FibrillationCalcium Channel BlockersCatheter AblationDigoxinDrug Therapy, CombinationElectrocardiography, AmbulatoryFemaleFollow-Up StudiesHeart RateHumansMaleMiddle AgedMultivariate AnalysisPacemaker, ArtificialStroke VolumeTreatment OutcomeConceptsCalcium channel blockersAtrial Fibrillation FollowAtrial fibrillationChannel blockersAFFIRM studyDrug classesFirst drugAdequate rate controlFirst drug classFrequent medication changesRhythm Management (AFFIRM) studyMajority of patientsBeta-adrenergic blockersRate control drugsElectrocardiographic resultsMedication changesWalk testInitial treatmentClinical variablesEfficacy criteriaDrug combinationsHeart rateEffective drugsPatientsMultivariate analysis
1992
Determinants of the hemodynamic consequence to sustained ventricular arrhythmias after a single myocardial infarction
Sager P, Perlmutter R, Rosenfeld L, Batsford W. Determinants of the hemodynamic consequence to sustained ventricular arrhythmias after a single myocardial infarction. American Heart Journal 1992, 124: 1484-1491. PMID: 1462903, DOI: 10.1016/0002-8703(92)90061-y.Peer-Reviewed Original ResearchConceptsProportion of patientsSustained ventricular tachycardiaStable sustained ventricular tachycardiaSustained ventricular arrhythmiasMyocardial infarctionCardiac arrestSingle myocardial infarctionVentricular arrhythmiasVentricular tachycardiaHemodynamic consequencesCA groupGlobal left ventricular ejection fractionLeft ventricular ejection fractionCongestive heart failureVentricular ejection fractionCoronary artery diseasePrevious myocardial infarctionAnterior wall infarctionBundle branch blockInferior wall infarctionArrhythmic cardiac arrestArtery diseaseEjection fractionHeart failureElectrophysiologic studyAntiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study
Sager P, Perlmutter R, Rosenfeld L, Batsford W. Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study. American Heart Journal 1992, 123: 926-933. PMID: 1550002, DOI: 10.1016/0002-8703(92)90698-u.Peer-Reviewed Original ResearchConceptsTest-negative groupInducible ventricular tachycardiaTest positive groupVentricular tachycardiaElectrophysiologic studyVentricular arrhythmiasClinical characteristicsSignificant organic heart diseaseInducible sustained ventricular tachycardiaDrug-induced exacerbationGroups' clinical characteristicsInducible ventricular arrhythmiasDrug testsVentricular ejection fractionVentricular tachycardia inductionOrganic heart diseaseSustained ventricular tachycardiaBundle branch blockDrug-free stateVentricular tachycardia inducibilityTachycardia inductionAntiarrhythmic therapyInducible arrhythmiasEjection fractionVentricular aneurysm